The Identification of Fibrosis-Driving Myofibroblast Precursors Reveals New Therapeutic Avenues in Myelofibrosis

Blood - United States
doi 10.1182/blood-2018-02-834820
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Cancer “Clock” Opens New Therapeutic Avenues

Cancer Discovery
Oncology
2017English

New Therapeutic Avenues of mCSF for Brain Diseases and Injuries

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2018English

Pathogenic Angiogenesis in IBD and Experimental Colitis: New Ideas and Therapeutic Avenues

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2007English

The Myofibroblast Matrix: Implications for Tissue Repair and Fibrosis

Journal of Pathology
Forensic MedicinePathology
2012English

Molecular Targets and Novel Therapeutic Avenues in Soft Tissue Sarcoma

Current Oncology
Oncology
2020English

Internuclear Bridging of Erythroid Precursors in the Peripheral Blood Smear in a Patient With Primary Myelofibrosis

Turkish Journal of Haematology
Hematology
2017English

New Avenues of Exploration for Erythropoietin

JAMA - Journal of the American Medical Association
Medicine
2005English

New Avenues of Value Creation in the Agro-Food Sector

OECD Food, Agriculture and Fisheries Papers
2009English

Lack of MK2 Inhibits Myofibroblast Formation and Exacerbates Pulmonary Fibrosis

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy